We are live on ! Find out more
ONCS

OncoSec Medical Incorporated

Delisted

ONCS was delisted on the 23rd of June, 2023.

0 hedge funds and large institutions have $0 invested in OncoSec Medical Incorporated in 2023 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 120 (-12)

100% less capital invested

Capital invested by funds: $665K → $0 (-$665K)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 12

Holders
Holders Change
-12
Holders Change %
-100%
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
12
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
FIA
1
FNY Investment Advisers
New York
-$272K -105,690 Closed
Vanguard Group
2
Vanguard Group
Pennsylvania
-$148K -57,488 Closed
State Street
3
State Street
Massachusetts
-$65K -25,187 Closed
SM
4
Salzhauer Michael
-$53.7K -20,799 Closed
Bank of New York Mellon
5
Bank of New York Mellon
New York
-$45K -17,434 Closed
LPL Financial
6
LPL Financial
California
-$44.9K -17,404 Closed
Geode Capital Management
7
Geode Capital Management
Massachusetts
-$27.1K -10,512 Closed
Wells Fargo
8
Wells Fargo
California
-$4.98K -1,929 Closed
BlackRock
9
BlackRock
New York
-$3.64K -1,410 Closed
Morgan Stanley
10
Morgan Stanley
New York
-$188 -73 Closed
Osaic Holdings
11
Osaic Holdings
Arizona
-$119 -46 Closed
Group One Trading
12
Group One Trading
Illinois
-$10 -4 Closed

ONCS Hedge Fund Activity: Q2 2023 in Review

0 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical Incorporated (ONCS) for Q2 2023, worth a combined $0 — down 100% from $665K a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of ONCS and 0 opened new positions — a net loss of 12 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was FNY Investment Advisers, exiting entirely with an estimated $272K sold.

  • 0 institutional investors held OncoSec Medical Incorporated (ONCS) as of Q2 2023, down from 12 in Q1 2023.
  • Funds reported $0 of OncoSec Medical Incorporated stock for Q2 2023, down 100% quarter-over-quarter.
  • 0 funds opened new OncoSec Medical Incorporated positions in Q2 2023 and 12 closed out, a net change of -12 holders.
  • The largest OncoSec Medical Incorporated seller in Q2 2023 was FNY Investment Advisers, an estimated $272K sold.

Based on aggregated 13F filings for Q2 2023.